The goal of this activity is for clinicians to be better able to adopt biosimilars through identifying patients with multiple sclerosis for whom these agents would be an appropriate treatment option and to reduce clinician and patient reluctance.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001503
- Start Date: 2024-08-23 05:00:00
- End Date: 2024-08-23 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest